Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
…, S Scherbeijn, L Gommers, RSG Sablerolles… - Science …, 2022 - science.org
The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …
[HTML][HTML] Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming
RSG Sablerolles, WJR Rietdijk… - … England Journal of …, 2022 - Mass Medical Soc
Background The Ad26.COV2.S vaccine, which was approved as a single-shot immunization
regimen, has been shown to be effective against severe coronavirus disease 2019. …
regimen, has been shown to be effective against severe coronavirus disease 2019. …
[HTML][HTML] Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective …
RSG Sablerolles, M Lafeber… - The Lancet Healthy …, 2021 - thelancet.com
Background During the COVID-19 pandemic, the scarcity of resources has necessitated
triage of critical care for patients with the disease. In patients aged 65 years and older, triage …
triage of critical care for patients with the disease. In patients aged 65 years and older, triage …
[HTML][HTML] Immunogenicity of bivalent omicron (BA. 1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON) …
NH Tan, D Geers, RSG Sablerolles… - The Lancet Infectious …, 2023 - thelancet.com
Background Bivalent mRNA-based COVID-19 vaccines encoding the ancestral and omicron
spike (S) protein were developed as a countermeasure against antigenically distinct SARS-…
spike (S) protein were developed as a countermeasure against antigenically distinct SARS-…
[HTML][HTML] Heterologous Ad26. COV2. S prime and mRNA-based boost COVID-19 vaccination regimens: the SWITCH trial protocol
RSG Sablerolles, A Goorhuis… - Frontiers in …, 2021 - frontiersin.org
Currently, four COVID-19 vaccines are authorized for use in the European Union by the
European Medicines Agency (EMA), ie, Ad26. COV2. S (1), ChAdOx1 nCoV-19 (2), mRNA1273 (…
European Medicines Agency (EMA), ie, Ad26. COV2. S (1), ChAdOx1 nCoV-19 (2), mRNA1273 (…
Durability of immune responses after boosting in Ad26. COV2. S-primed healthcare workers
RSG Sablerolles, WJR Rietdijk… - Clinical Infectious …, 2023 - academic.oup.com
The emergence of SARS-CoV-2 variants raised questions regarding the durability of immune
responses after homologous or heterologous boosters after Ad26.COV2.S-priming. We …
responses after homologous or heterologous boosters after Ad26.COV2.S-priming. We …
[PDF][PDF] Ad26. COV2. S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
D Geers, RSG Sablerolles, D van Baarle, NA Kootstra… - Iscience, 2023 - cell.com
The emergence of novel SARS-CoV-2 variants led to the recommendation of booster
vaccinations after Ad26.COV2.S priming. It was previously shown that heterologous booster …
vaccinations after Ad26.COV2.S priming. It was previously shown that heterologous booster …
[HTML][HTML] Age moderates the effect of obesity on mortality risk in critically ill patients with COVID-19: a nationwide observational cohort study
…, WJR Rietdijk, RSG Sablerolles… - Critical Care …, 2023 - journals.lww.com
OBJECTIVES: A high body mass index (BMI) is associated with an unfavorable disease course
in COVID-19, but not among those who require admission to the ICU. This has not been …
in COVID-19, but not among those who require admission to the ICU. This has not been …
[HTML][HTML] Analyzing the immunogenicity of bivalent booster vaccinations in healthcare workers: The SWITCH ON trial protocol
NH Tan, RSG Sablerolles, WJR Rietdijk… - Frontiers in …, 2022 - frontiersin.org
Vaccination against coronavirus disease 2019 (COVID-19) has contributed greatly to providing
protection against severe disease, thereby reducing hospital admissions and deaths. …
protection against severe disease, thereby reducing hospital admissions and deaths. …
Evaluation of bivalent omicron Ba. 1 booster vaccination after different priming regimens in healthcare workers (Switch on): A randomized controlled trial
NH Tan, D Geers, RSG Sablerolles, WJR Rietdijk… - medRxiv, 2022 - medrxiv.org
Background Bivalent mRNA-based COVID-19 vaccines encoding the ancestral and Omicron
spike protein were developed as a countermeasure against antigenically distinct SARS-…
spike protein were developed as a countermeasure against antigenically distinct SARS-…